(5S,7R,8R,9R,10aR,11R,12R,13S,14aS,15R)-3-(3,4-dihydroxyphenyl)-11,12,15-trihydroxy-7-(hydroxymethyl)-13-methyloctahydro-7H,11H-5,9-methanopyrano[2,3-g][1,3,6,9]tetraoxacyclododecin-8-yl (E)-3-(3,4-dihydroxyphenyl)acrylate

Catalog No. :: ACJYDM072
CAS No. :: 1233510-75-2
Molecular Formula :: C29H34O15
Molecular Weight :: 622.58

IUPAC Name:(5S,7R,8R,9R,10aR,11R,12R,13S,14aS,15R)-3-(3,4-dihydroxyphenyl)-11,12,15-trihydroxy-7-(hydroxymethyl)-13-methyloctahydro-7H,11H-5,9-methanopyrano[2,3-g][1,3,6,9]tetraoxacyclododecin-8-yl (E)-3-(3,4-dihydroxyphenyl)acrylate

(5S,7R,8R,9R,10aR,11R,12R,13S,14aS,15R)-3-(3,4-dihydroxyphenyl)-11,12,15-trihydroxy-7-(hydroxymethyl)-13-methyloctahydro-7H,11H-5,9-methanopyrano[2,3-g][1,3,6,9]tetraoxacyclododecin-8-yl (E)-3-(3,4-dihydroxyphenyl)acrylate structure diagram

No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

0 Reviews:View Reviews

Product Information

Product Name	(5S,7R,8R,9R,10aR,11R,12R,13S,14aS,15R)-3-(3,4-dihydroxyphenyl)-11,12,15-trihydroxy-7-(hydroxymethyl)-13-methyloctahydro-7H,11H-5,9-methanopyrano[2,3-g][1,3,6,9]tetraoxacyclododecin-8-yl (E)-3-(3,4-dihydroxyphenyl)acrylate
IUPAC Name	(5S,7R,8R,9R,10aR,11R,12R,13S,14aS,15R)-3-(3,4-dihydroxyphenyl)-11,12,15-trihydroxy-7-(hydroxymethyl)-13-methyloctahydro-7H,11H-5,9-methanopyrano[2,3-g][1,3,6,9]tetraoxacyclododecin-8-yl (E)-3-(3,4-dihydroxyphenyl)acrylate
Molecular Formula	C29H34O15
Molecular Weight	622.58
SMILES	C[C@@H]1O[C@@H]2OCC(C3=CC(O)=C(O)C=C3)O[C@H]3O[C@H](CO)[C@@H](OC(=O)/C=C/C4=CC(O)=C(O)C=C4)[C@H](O[C@@H]2[C@H](O)[C@H]1O)[C@H]3O
InChI Key	YCPGXBUTQCIAHS-HPRNYKHHSA-N
Synonym	α-D-Glucopyranose, 3-O-(2,6-dideoxy-β-L-mannopyranos-2-yl)-1,1'-[1-(3,4-dihydroxyphenyl)-1,2-ethanediyl]-, 4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate];Anhuienoside B
CAS No.	1233510-75-2

Synthetic Route by SureRoute

--
ACJYDM0721233510-75-2

Inquiry

--
ACJYDM0721233510-75-2

Inquiry

Recently Added

(5S,7R,8R,9R,10aR,11R,12R,13S,14aS,15R)-3-(3,4-dihydroxyphenyl)-11,12,15-trihydroxy-7-(hydroxymethyl)-13-methyloctahydro-7H,11H-5,9-methanopyrano[2,3-g][1,3,6,9]tetraoxacyclododecin-8-yl (E)-3-(3,4-dihydroxyphenyl)acrylate

Product Information

Synthetic Route by SureRoute

1. ACJYDM072 Molecular Building Block Synthetic Route

2. ACJYDM072 Molecular Building Block Synthetic Route

Comments (0)

(5S,7R,8R,9R,10aR,11R,12R,13S,14aS,15R)-3-(3,4-dihydroxyphenyl)-11,12,15-trihydroxy-7-(hydroxymethyl)-13-methyloctahydro-7H,11H-5,9-methanopyrano[2,3-g][1,3,6,9]tetraoxacyclododecin-8-yl (E)-3-(3,4-dihydroxyphenyl)acrylate

Product Information

Synthetic Route by SureRoute

(4aR,6R,7R,8S,8aS)-2-(3,4-dihydroxyphenyl)-6-(hydroxymethyl)-8-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexahydro-6H-pyrano[2,3-b][1,4]dioxin-7-yl (E)-3-(3,4-dihydroxyphenyl)acrylate

Isocrenatoside

Campneoside II

(2R,3R,4R,5R,6R)-6-(2-(3,4-Dihydroxyphenyl)-2-hydroxyethoxy)-5-hydroxy-2-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)-4-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl (E)-3-(3,4-dihydroxyphenyl)acrylate

Comments (0)